HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. HPV16 CTL epitopes may be good candidates for the development of an effective peptide-based antitumor vaccine.
Peptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C₅₃H₈₃N₁₁O₁₉S |
M.W/Mr. | 1210.35 |
Sequence | One Letter Code: YMLDLQPETT three Letter Code: Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Thr |
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com